Virtual Library

Start Your Search

S. Wang

Author of

  • +

    Best abstracts selected from submissions 4 (ID 4)

    • Event: ACLC 2018
    • Type: Oral Session
    • Track:
    • Presentations: 1
    • +

      OA08 - Efficacy and Safety of Sintilimab Combined with 1st Line Chemotherapy in Advanced Squamous Cell Non-small Cell Lung Cancer (ID 99)

      10:50 - 11:30  |  Author(s): S. Wang

      • Abstract
      • Slides

      Sintilimab, a novel full-humanized IgG4 anti-PD-1 monoclonal antibody, showed its potent anti-tumor efficacy in preclinical models. Hence, we evaluated the efficacy and safety of sintilimab in combination with gemcitabine and cisplatin in treatment na

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.